{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:16:24Z","timestamp":1767906984549,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T00:00:00Z","timestamp":1389052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>With the rapid development of high-throughput genomic technologies and the accumulation of genome-wide datasets for gene expression profiling and biological networks, the impact of diseases and drugs on gene expression can be comprehensively characterized. Drug repositioning offers the possibility of reduced risks in the drug discovery process, thus it is an essential step in drug development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Computational prediction of drug-disease interactions using gene expression profiling datasets and biological networks is a new direction in drug repositioning that has gained increasing interest. We developed a computational framework to build disease-drug networks using drug- and disease-specific subnetworks. The framework incorporates protein networks to refine drug and disease associated genes and prioritize genes in disease and drug specific networks. For each drug and disease we built multiple networks using gene expression profiling and text mining. Finally a logistic regression model was used to build functional associations between drugs and diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We found that representing drugs and diseases by genes with high centrality degree in gene networks is the most promising representation of drug or disease subnetworks.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1758-2946-6-1","type":"journal-article","created":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T14:01:32Z","timestamp":1389103292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Prediction of novel drug indications using network driven biological data prioritization and integration"],"prefix":"10.1186","volume":"6","author":[{"given":"Ala","family":"Qabaja","sequence":"first","affiliation":[]},{"given":"Mohammed","family":"Alshalalfa","sequence":"additional","affiliation":[]},{"given":"Eisa","family":"Alanazi","sequence":"additional","affiliation":[]},{"given":"Reda","family":"Alhajj","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,1,7]]},"reference":[{"issue":"2","key":"490_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","volume":"22","author":"J DiMasi","year":"2003","unstructured":"DiMasi J, Hansen R, Grabowski H: The price of innovation: new estimates of drug development costs. J Health Econ. 2003, 22 (2): 151-185. 10.1016\/S0167-6296(02)00126-1.","journal-title":"J Health Econ"},{"issue":"7154","key":"490_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/448645a","volume":"448","author":"C Chong","year":"2007","unstructured":"Chong C, Sullivan D: New uses for old drugs. Nature. 2007, 448 (7154): 645-646. 10.1038\/448645a.","journal-title":"Nature"},{"issue":"3","key":"490_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.tips.2009.11.006","volume":"31","author":"A Pujol","year":"2010","unstructured":"Pujol A, Mosca R, Farr\u00e9s J, Aloy P: Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol Sci. 2010, 31 (3): 115-123. 10.1016\/j.tips.2009.11.006.","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"490_CR4","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nrd2748","volume":"7","author":"D Jones","year":"2008","unstructured":"Jones D: Pathways to cancer therapy. Nat Rev Drug Discov. 2008, 7 (11): 875-876. 10.1038\/nrd2748.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"490_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.compbiolchem.2007.06.001","volume":"31","author":"Y Yap","year":"2007","unstructured":"Yap Y, Zhang X, Smith D, Soong R, Hill J: Molecular gene expression signature patterns for gastric cancer diagnosis. Comput Biol Chem. 2007, 31 (4): 275-287. 10.1016\/j.compbiolchem.2007.06.001.","journal-title":"Comput Biol Chem"},{"issue":"18","key":"490_CR6","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1200\/JCO.2007.13.5806","volume":"26","author":"C Walsh","year":"2008","unstructured":"Walsh C, Ogawa S, Karahashi H, Scoles D, Pavelka J: ERCC5 is a novel biomarker of ovarian cancer prognosis. J Clin Oncol. 2008, 26 (18): 2952-2958. 10.1200\/JCO.2007.13.5806.","journal-title":"J Clin Oncol"},{"issue":"1","key":"490_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.joca.2008.05.008","volume":"17","author":"W Wang","year":"2009","unstructured":"Wang W, Guo X, Duan C, Ma W, Zhang Y: Comparative analysis of gene expression profiles between the normal human cartilage and the one with endemic osteoarthritis. Osteoarthritis Cartilage. 2009, 17 (1): 83-90. 10.1016\/j.joca.2008.05.008.","journal-title":"Osteoarthritis Cartilage"},{"issue":"8","key":"490_CR8","doi-asserted-by":"publisher","first-page":"e6536","DOI":"10.1371\/journal.pone.0006536","volume":"4","author":"G Hu","year":"2009","unstructured":"Hu G, Agarwal P: Human disease-drug network based on genomic expression profiles. PloS One. 2009, 4 (8): e6536-10.1371\/journal.pone.0006536.","journal-title":"PloS One"},{"issue":"5629","key":"490_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1126\/science.1081900","volume":"301","author":"T Gardner","year":"2003","unstructured":"Gardner T, di Bernardo D, Lorenz D, JJ C: Inferring genetic networks and identifying compound mode of action via expression profiling. Science. 2003, 301 (5629): 102-107. 10.1126\/science.1081900.","journal-title":"Science"},{"issue":"5795","key":"490_CR10","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford E, Peck D, Modell J, Blat I, Wrobel M, Lerner J, Brunet J, Subramanian A, Ross K, Reich M, Lander E, Golub T: The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease. Science. 2006, 313 (5795): 1929-1935. 10.1126\/science.1132939.","journal-title":"Science"},{"issue":"96","key":"490_CR11","doi-asserted-by":"publisher","first-page":"96ra77","DOI":"10.1126\/scitranslmed.3001318","volume":"3","author":"M Sirota","year":"2011","unstructured":"Sirota M, Dudley J, Kim J, Sage J, Butte A: Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med. 2011, 3 (96): 96ra77-","journal-title":"Sci Transl Med"},{"issue":"33","key":"490_CR12","doi-asserted-by":"publisher","first-page":"14621","DOI":"10.1073\/pnas.1000138107","volume":"107","author":"F Iorio","year":"2010","unstructured":"Iorio F, Bosotti R, Scacheri E, Isacchi A, di Bernardo D: Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci USA. 2010, 107 (33): 14621-14627. 10.1073\/pnas.1000138107.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"43","key":"490_CR13","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha V, Golub T, Lander E, Mesirov J: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005, 102 (43): 15545-15550. 10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"490_CR14","doi-asserted-by":"publisher","first-page":"W334","DOI":"10.1093\/nar\/gkr289","volume":"39","author":"D Nitsch","year":"2011","unstructured":"Nitsch D, Tranchevent L, Gon\u00e7alves J, Vogt J, Madeira S, Moreau Y: PINTA: a web server for network-based gene prioritization from expression data. Nucleic Acids Res. 2011, 39: W334-W338. 10.1093\/nar\/gkr289.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"490_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nbt.1522","volume":"27","author":"I Taylor","year":"2009","unstructured":"Taylor I, Linding R, Warde-Farley D, Pawson T, Morris Q, Wrana J: Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nature Biotechnol. 2009, 27 (2): 199-204. 10.1038\/nbt.1522.","journal-title":"Nature Biotechnol"},{"issue":"7","key":"490_CR16","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/bioinformatics\/btq051","volume":"26","author":"A Reverter","year":"2010","unstructured":"Reverter A, Hudson N, Nagaraj S, P\u00e9rez-Enciso M, Dalrymple B: Regulatory impact factors: unraveling the transcriptional regulation of complex traits from expression data. Bioinformatics. 2010, 26 (7): 896-904. 10.1093\/bioinformatics\/btq051.","journal-title":"Bioinformatics"},{"key":"490_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/1471-2105-13-182","volume":"13","author":"C Wu","year":"2012","unstructured":"Wu C, Zhu J, Zhang X: Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes. BMC Bioinformatics. 2012, 13: 182-195. 10.1186\/1471-2105-13-182.","journal-title":"BMC Bioinformatics"},{"key":"490_CR18","doi-asserted-by":"publisher","first-page":"W399","DOI":"10.1093\/nar\/gkn296","volume":"36","author":"D Cheng","year":"2008","unstructured":"Cheng D, Knox C, Young N, Stothard P, Damaraju S, Wishart D: PolySearch: a web-based text mining system for extracting relationships between human diseases, genes, mutations, drugs and metabolites. Nucleic Acids Res. 2008, 36: W399-W405. 10.1093\/nar\/gkn296.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"490_CR19","doi-asserted-by":"publisher","first-page":"e1000450","DOI":"10.1371\/journal.pcbi.1000450","volume":"5","author":"J Li","year":"2009","unstructured":"Li J, Zhu X, Chen J: Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts. PLoS Comput Biol. 2009, 5 (7): e1000450-10.1371\/journal.pcbi.1000450.","journal-title":"PLoS Comput Biol"},{"key":"490_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-2105-10-73","volume":"10","author":"J Chen","year":"2009","unstructured":"Chen J, Aronow B, Jegga A: Disease candidate gene identification and prioritization using protein interaction networks. BMC Bioinformatics. 2009, 10: 73-83. 10.1186\/1471-2105-10-73.","journal-title":"BMC Bioinformatics"},{"issue":"13","key":"490_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/bioinformatics\/btn182","volume":"24","author":"A Ozg\u00fcr","year":"2008","unstructured":"Ozg\u00fcr A, Vu T, Erkan G, Radev D: Identifying gene-disease associations using centrality on a literature mined gene-interaction network. Bioinformatics. 2008, 24 (13): 277-285. 10.1093\/bioinformatics\/btn182.","journal-title":"Bioinformatics"},{"key":"490_CR22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/msb.2011.26","volume":"7","author":"A Gottlieb","year":"2011","unstructured":"Gottlieb A, Stein G, Ruppin E, Sharan R: PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol. 2011, 7: 496-","journal-title":"Mol Syst Biol"},{"issue":"1","key":"490_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nbt1273","volume":"25","author":"A Cheng","year":"2007","unstructured":"Cheng A, Coleman R, Smith K, Cao Q, Soulard P, Caffrey D, Salzberg A, Huang E: Structure-based maximal affinity model predicts small-molecule druggability. Nat Biotechnol. 2007, 25 (1): 71-76. 10.1038\/nbt1273.","journal-title":"Nat Biotechnol"},{"key":"490_CR24","doi-asserted-by":"publisher","first-page":"D1035","DOI":"10.1093\/nar\/gkq1126","volume":"39","author":"C Knox","year":"2011","unstructured":"Knox C, Law V, Jewison T, Guo A, Wishart D: DrugBank 3.0: a comprehensive resource for \u2018omics\u2019 research on drugs. Nucleic Acids Res. 2011, 39: D1035-D1041. 10.1093\/nar\/gkq1126.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"490_CR25","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/gb-2010-11-5-r53","volume":"11","author":"G Wu","year":"2010","unstructured":"Wu G, Feng X, Stein L: A human functional protein interaction network and its application to cancer data analysis. Genome Biol. 2010, 11 (5): R53-10.1186\/gb-2010-11-5-r53.","journal-title":"Genome Biol"},{"issue":"5795","key":"490_CR26","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford E, Peck D, Modell J, Blat I, Wrobel M, Lerner J, Brunet J, Subramanian A, Ross K, Reich M, Lander E, Golub T: The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease. Science. 2006, 313 (5795): 1929-1935. 10.1126\/science.1132939.","journal-title":"Science"},{"key":"490_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/nar\/gng015","volume":"31","author":"R Irizarry","year":"2003","unstructured":"Irizarry R, Bolstad B, Collin F, Cope L, Hobbs B, Speed T: Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31: 4-10.1093\/nar\/gng004.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"490_CR28","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"V Tusher","year":"2001","unstructured":"Tusher V, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001, 98 (9): 5116-51121. 10.1073\/pnas.091062498.","journal-title":"Proc Natl Acad Sci USA"},{"key":"490_CR29","doi-asserted-by":"publisher","first-page":"D561","DOI":"10.1093\/nar\/gkq973","volume":"39","author":"D Szklarczyk","year":"2011","unstructured":"Szklarczyk D, Franceschini A, Jensen L, Mering C: The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011, 39: D561-D568. 10.1093\/nar\/gkq973.","journal-title":"Nucleic Acids Res"},{"key":"490_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/msb4100200","volume":"3","author":"Q Cui","year":"2007","unstructured":"Cui Q, Ma Y, Jaramillo M, Purisima E, Wang E: A map of human cancer signaling. Mol Syst Biol. 2007, 3: 152-","journal-title":"Mol Syst Biol"},{"key":"490_CR31","volume-title":"AAAI Conference on Weblogs and Social Media","author":"M Bastian","year":"2009","unstructured":"Bastian M, Heymann S, Jacomy M: Gephi: an open source software for exploring and manipulating networks. AAAI Conference on Weblogs and Social Media. 2009,"},{"issue":"2","key":"490_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1677\/ERC-08-0130","volume":"16","author":"C Festuccia","year":"2009","unstructured":"Festuccia C, Gravina G, D\u2019Alessandro A, Vicentini C, Bologna M: Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models. Endocr Relat Cancer. 2009, 16 (2): 401-413. 10.1677\/ERC-08-0130.","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"490_CR33","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/pros.20748","volume":"68","author":"G Gravina","year":"2008","unstructured":"Gravina G, Festuccia C, Millimaggi D, Dolo V, Vicentini B: Chronic Azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells. Rostate. 2008, 68 (7): 793-801.","journal-title":"Rostate"},{"issue":"1","key":"490_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mrfmmm.2012.04.005","volume":"734","author":"Y Wang","year":"2012","unstructured":"Wang Y, Liu Q, Gong Y, Shao C: Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells. Mutat Res. 2012, 734 (1): 20-29.","journal-title":"Mutat Res"},{"issue":"8","key":"490_CR35","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1158\/1535-7163.MCT-10-0985","volume":"10","author":"J Li","year":"2011","unstructured":"Li J, Cao B, Dong Y: Berberine suppresses androgen receptor signaling in prostate cancer. Mol Cancer Ther. 2011, 10 (8): 1346-1356. 10.1158\/1535-7163.MCT-10-0985.","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"490_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00262-011-0988-4","volume":"60","author":"Q He","year":"2011","unstructured":"He Q, Li J, Yin W, Gao J: Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer. Cancer Immuno Immunother. 2011, 60 (5): 715-730. 10.1007\/s00262-011-0988-4.","journal-title":"Cancer Immuno Immunother"},{"issue":"6","key":"490_CR37","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.juro.2011.07.088","volume":"186","author":"P Lu","year":"2011","unstructured":"Lu P, Yu C, Chiang P, Chen Y, Ho Y, Kung F, Guh F: Paclitaxes induces apoptosis through activation of nuclear protein kinas and subsequent activation of Golgi associated Cdk1 in human hormone refractory prostate cancer. J Urol. 2011, 186 (6): 2434-2441. 10.1016\/j.juro.2011.07.088.","journal-title":"J Urol"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1758-2946-6-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-2946-6-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-2946-6-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:49:08Z","timestamp":1630550948000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/1758-2946-6-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["490"],"URL":"https:\/\/doi.org\/10.1186\/1758-2946-6-1","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,7]]},"assertion":[{"value":"23 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"1"}}